Health & Biotech
Q+A: Mach 7 CEO Mike Lampron on a barnstorming year and why AI isn’t the easy win it looks like
Health & Biotech
mRNA is the next big thing in medicine. Here’s why Noxopharm could be the ASX front runner in this field
Health & Biotech
ASX Health Stocks: Chimeric surges 70pc after FDA approval, takes its CAR T cell drug to the clinic
Health & Biotech
ASX Health Stocks: Amplia’s pancreatic cancer trial gets boost; Emyria’s MDMA therapy is one step closer
Health & Biotech
‘Diagnose on the spot’: Optiscan’s platform brings together surgeons and pathologists for better cancer outcomes
Health & Biotech
ScoPo’s Powerplays: Who fancies a ‘MedWalk intervention’? Oh, and ASX healthcare stocks can’t catch a break
Health & Biotech
ASX Health Stocks: Earnings season is in full swing. We pick three highlights from the Health sector
Health & Biotech
Weed Week: US House Speaker ousting could boost weed stocks; TGA urged to allow the term ‘medicinal cannabis’
Health & Biotech
Q&A: Immutep’s CEO on improving lung cancer survival, and where to next after trial success
Health & Biotech
ASX Health Stocks: Althea’s cannabis oil approved for reimbursement in Ireland, Imugene begins Phase 1 trial
Health & Biotech
China’s Silk Road for health and wellness is now even more of a two-way street with Australia
Health & Biotech
ASX Health Stocks: Recce moves forward in Phase 1/2 study; EMV unveils Gen 2 helmet scanner for ambulance
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.